Elevance Health (ELV) reported quarterly EPS of $7.45, beating the Zacks Consensus Estimate of $6.18 by $1.27 (+20.6%). EPS declined from $8.84 a year ago, indicating year-over-year pressure despite the upside versus expectations.
Elevance Health (ELV) reported quarterly EPS of $7.45, beating the Zacks Consensus Estimate of $6.18 by $1.27 (+20.6%). EPS declined from $8.84 a year ago, indicating year-over-year pressure despite the upside versus expectations.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
